IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023

RESEARCH TRIANGLE PARK, N.C., April 20, 2023--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announces the company has been recognized as a Leader in Customer Experience Platforms (CXP) by Everest Group for its Orchestrated Customer Engagement (OCE) platform.

The IQVIA OCE platform was recognized as a Leader in the CXP pharma provider sector for its well-rounded portfolio of industry-leading products, which offer the ability to drive better customer engagement. OCE is Salesforce-based and provides a full spectrum of capabilities, from every personal and digital engagement need to optimization tools that ensure all resources and assets are utilized to maximum efficiency.

"We’re pleased that Everest Group recognizes IQVIA as an industry Leader for the OCE platform, which enhances the customer experience for our clients," said Sanjay Chikarmane, Chief Product Officer, IQVIA. "OCE is the only Salesforce-based technology purpose built for Life Science companies across every region in the world, and our end-to-end product suite enables commercial success in an environment that’s never been more demanding."

"IQVIA's OCE suite of solutions, particularly its strong customer engagement and content management capabilities which backed by actionable recommendations and analytics, are highly appreciated by clients," said Chunky Satija, Vice President, Everest Group. "Customers consider its experience with large biopharma companies and ability to share industry best practices as a differentiator, hence earning its Leader position."

To review the complete report, including details on IQVIA’s leader status, please click here.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230420005606/en/

Contacts

Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)
+1.973.316.3828

Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)
+1.919.780.3221